⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL614949 | 0.91 | — | — | |
| SCHEMBL614444 | 0.85 | — | — | |
| SCHEMBL612313 | 0.74 | ADRB2 (0.41) | — | |
| SCHEMBL818694 | 0.73 | — | — | |
| SCHEMBL567818 | 0.73 | — | — | |
| SCHEMBL23701003 | 0.71 | — | — | |
| SCHEMBL1608777 | 0.71 | — | — | |
| SCHEMBL8086469 | 0.71 | — | — | |
| SCHEMBL766415 | 0.71 | — | — | |
| SCHEMBL4612833 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106574116-B | Curable composition, cured product, method for using curable composition, and optical device | 琳得科株式会社 | 2020-07-14 | — | — | CN | disclosed |
| EP-1999167-A2 | ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR | Novolen Technology Holdings, C.V. (NL) | 2008-12-10 | — | — | EP | disclosed |
| WO-2007106348-A2 | ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR | NOVOLEN TECHNOLOGY HOLDINGS C.V. (NL) | 2007-09-20 | — | — | WO | disclosed |
| US-20070213204-A1 | Ziegler-Natta catalyst with in situ-generated donor | NOVOLEN TECHNOLOGY HOLDINGS C.V. | 2007-09-13 | — | — | US | disclosed |